Geetanjali Cred. (539486)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at ₹4 against book value of ₹6.76, a 41% discount to stated assets (P/B 0.59).
• Losses are small relative to book value, as ROE is only -1.92%, not a major cash drain yet.
• 52-week range of ₹3.13 to ₹7.03 shows the stock is near the lower end, reducing further downside if book value holds.
• No dividend obligation means cash is not being paid out while the company stabilizes.

Concerns

• Latest quarter sales are ₹0 Cr and profit is effectively ₹0 Cr; an NBFC with no earning assets or operations is not a going concern.
• Negative ROE and ROCE indicate capital is not generating any return and equity is being eroded.
• Piotroski F-Score of 2/9 signals very weak financial health and possible accounting or operational red flags.
• Promoter holding and debt/equity data are not available, making it difficult to assess ownership, leverage, and governance.

AI Analysis

At ₹4 per share against a stated book value of ₹6.76, Geetanjali Cred. looks like a classic Graham asset play. But let me slow down. A P/B of 0.59 means the market is giving me 41 paise of discount on every rupee of book value. That sounds like a margin of safety, but only if that book value is real and productive. Here, it is not productive. ROE is -1.92% and ROCE is -0.96%. The latest quarter shows sales of ₹0 Cr and net profit of ₹-0 Cr. An NBFC with no revenue and no profit is not a business; it is a shell. In my framework, the best things are simple, growing, and earn high returns on capital. This has none of those. Worse, the Piotroski F-Score is 2 out of 9, which is a warning signal about financial health. A score that low tells me the company may be burning value, not building it. The market cap is just ₹2 Cr, so this is a tiny, illiquid name. I cannot rely on price discovery or an active board. The absence of promoter holding and debt-equity data also bothers me. I like to know who owns the business and how much leverage it carries before I commit money. Buying this is not investing; it is speculation on a cheap balance sheet. As Graham would say, price is what you pay, value is what you get. Here, the value is uncertain and the price, while low, may be a value trap. I would only look closer if the company starts earning again and proves that those assets can generate returns. Until then, this is a cigar butt with one or two puffs left — if that.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer